This is not the most recent version of the article. View current version (16 FEB 2011)

Intervention Protocol

Edaravone for acute intracerebral haemorrhage

  1. Jie Yang2,
  2. Ming Liu1,*,
  3. Junshan Zhou3,
  4. Shihong Zhang1,
  5. Sen Lin1,
  6. Hongdong Zhao3

Editorial Group: Cochrane Stroke Group

Published Online: 15 APR 2009

Assessed as up-to-date: 13 DEC 2008

DOI: 10.1002/14651858.CD007755


How to Cite

Yang J, Liu M, Zhou J, Zhang S, Lin S, Zhao H. Edaravone for acute intracerebral haemorrhage (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007755. DOI: 10.1002/14651858.CD007755.

Author Information

  1. 1

    West China Hospital, Sichuan University, Department of Neurology, Chengdu, Sichuan Province, China

  2. 2

    (b) Department of Neurology, Nanjing First Hospital, (a) Department of Neurology, West China Hospital, Sichuan University, Chengdu, China, Nanjing, Jiangsu, China

  3. 3

    Nanjing First Hospital, Department of Neurology, Nanjing, Jiangsu, China

*Ming Liu, Department of Neurology, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan Province, 610041, China. wyplmh@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 15 APR 2009

SEARCH

This is not the most recent version of the article. View current version (16 FEB 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the safety and efficacy of edaravone for acute intracerebral haemorrhage.